The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

BACKGROUND: Neurological disability progression occurs across the spectrum of people living with multiple sclerosis (MS). Although there are a handful of disease-modifying treatments approved for use in progressive phenotypes of MS, there are no treatments that substantially modify the course of cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jiwon, Arbour, Nathalie, Giuliani, Fabrizio, Guenette, Melanie, Kolind, Shannon, Lynd, Larry, Marrie, Ruth Ann, Metz, Luanne M., Patten, Scott B., Prat, Alexandre, Schabas, Alice, Smyth, Penelope, Tam, Roger, Traboulsee, Anthony, Yong, V. Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549411/
https://www.ncbi.nlm.nih.gov/pubmed/34706670
http://dx.doi.org/10.1186/s12883-021-02447-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549411/
https://www.ncbi.nlm.nih.gov/pubmed/34706670
http://dx.doi.org/10.1186/s12883-021-02447-7

Ejemplares similares